Clinical Trials Logo

Clinical Trial Summary

Objective: To evaluate the effects of perioperative glutamine supplemented total parenteral nutrition support on nutritional status, immunologic function and intestinal permeability of patients with chronic radiation intestinal injury.

Methods: The 40 patients with CRII were randomized into two groups, the standard TPN group and glutamine-enriched TPN group. The patients were administered total parenteral nutrition for at least four weeks (two weeks pre-operation and two weeks post-operation). The nutritional status, immunologic function, plasma concentration of glutamine and intestinal permeability were measured at 1 day, 1 week and 2 weeks pre-operation, 3 day, 1 week and 2 weeks post-operation. Nutrition status was determined the plasma concentrations of hemoglobin, albumin, prealbumin, transferrin and triglyceride. Immunologic function were measured by the percentages of CD4+T cells and CD8+T cells, the ratio of CD4 +T cells to CD8+T cells ( CD4 +/CD8 +) was calculated, and serum IgA, IgM and IgG.The intestinal permeability was detected by the urinal ratio of lactulose and mannitol.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01758783
Study type Interventional
Source Nanjing University School of Medicine
Contact
Status Enrolling by invitation
Phase N/A
Start date June 2012
Completion date July 2013

See also
  Status Clinical Trial Phase
Recruiting NCT05425901 - Preclinical Evaluation of Multimodal Therapeutic Strategies in Intestinal Irradiation and Inflammatory Bowel Disease From Organoids N/A
Completed NCT01545063 - CAre of Patients With PArenteral Nutrition At Home N/A
Recruiting NCT05138887 - A Study for Assessing the Efficacy and Safety of BH4 in Radiation Enteritis Phase 2
Completed NCT00003825 - Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy Phase 3
Recruiting NCT03516461 - Microbiota Transplantation for Radiation Enteritis N/A
Completed NCT00075868 - Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer Phase 3
Recruiting NCT05728060 - Associations of Fecal Bile Acid Profile and Intestinal Flora With Chronic Radiation Enteritis
Recruiting NCT01414517 - Study to Prevent Radiation Induced Damage to Bowel Using a Prebiotic Enhanced Diet. Phase 3